HCA Healthcare, Inc.
HCA Healthcare Medical Care Facilities
HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024. In the quarter to June 2026, revenue grew 8.73%, EPS grew 11.6%, free cash flow fell 63.6% and total debt rose 11.8%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for ten, operating cash flow growth for three.
Follow HCA
HCA Healthcare, Inc. (HCA) Shares outstanding
HCA Healthcare, Inc.'s shares outstanding at the end of fiscal 2025 was $239.5M, down 8.52% from $261.8M in fiscal 2024. At the end of the quarter to 30 June 2026 it was $222.8M. Over the past ten years it has ranged from $239.5M (fiscal 2025) to $426.7M (fiscal 2015) — the current reading is the lowest in ten years. HCA Healthcare, Inc. ranks 5th of 52 Medical Care Facilities companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $239.5M | (8.52%) |
| FY2024 | $261.8M | (5.28%) |
| FY2023 | $276.4M | (6.19%) |
| FY2022 | $294.7M | (10.37%) |
| FY2021 | $328.8M | (4.32%) |
| FY2020 | $343.6M | (1.33%) |
| FY2019 | $348.2M | (1.99%) |
| FY2018 | $355.3M | (4.55%) |
| FY2017 | $372.2M | (5.97%) |
| FY2016 | $395.9M | (7.23%) |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $222.8M | (1.69%) |
| Mar 2026 | $226.7M | (5.36%) |
| Dec 2025 | $239.5M | 1.40% |
| Sep 2025 | $236.2M | (2.37%) |
| 42 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | $536.9M |
| HCA HCA Healthcare, Inc. | $222.8M |
| PACS PACS Group, Inc. compare | $162.0M |
| EHC Encompass Health Corporation compare | $100.0M |
| THC Tenet Healthcare Corporation compare | $84.0M |
| DVA DaVita Inc. compare | $66.1M |
| UHS Universal Health Services, Inc. compare | $59.9M |
| ENSG The Ensign Group, Inc. compare | $59.5M |
| CHE Chemed Corporation compare | $13.2M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on HCA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement